BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16690931)

  • 1. Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves.
    Valarcher JF; Furze J; Wyld SG; Cook R; Zimmer G; Herrler G; Taylor G
    J Gen Virol; 2006 Jun; 87(Pt 6):1659-1667. PubMed ID: 16690931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.
    Taylor G; Wyld S; Valarcher JF; Guzman E; Thom M; Widdison S; Buchholz UJ
    J Gen Virol; 2014 Jun; 95(Pt 6):1244-1254. PubMed ID: 24700100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.
    Schmidt U; Beyer J; Polster U; Gershwin LJ; Buchholz UJ
    J Virol; 2002 Dec; 76(23):12355-9. PubMed ID: 12414977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.
    Valarcher JF; Furze J; Wyld S; Cook R; Conzelmann KK; Taylor G
    J Virol; 2003 Aug; 77(15):8426-39. PubMed ID: 12857912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.
    Zimmer G; Conzelmann KK; Herrler G
    J Virol; 2002 Sep; 76(18):9218-24. PubMed ID: 12186905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
    Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
    PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel protein expression strategy using recombinant bovine respiratory syncytial virus (BRSV): modifications of the peptide sequence between the two furin cleavage sites of the BRSV fusion protein yield secreted proteins, but affect processing and function of the BRSV fusion protein.
    König P; Giesow K; Schuldt K; Buchholz UJ; Keil GM
    J Gen Virol; 2004 Jul; 85(Pt 7):1815-1824. PubMed ID: 15218165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine model of respiratory syncytial virus infection.
    Taylor G
    Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
    Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
    J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus.
    Zimmer G; Rohn M; McGregor GP; Schemann M; Conzelmann KK; Herrler G
    J Biol Chem; 2003 Nov; 278(47):46854-61. PubMed ID: 12952986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.
    Ellis JA; West KH; Waldner C; Rhodes C
    Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine respiratory syncytial virus infection: immunopathogenic mechanisms.
    Gershwin LJ
    Anim Health Res Rev; 2007 Dec; 8(2):207-13. PubMed ID: 18218161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.
    Ellis J; Gow S; Berenik A; Lacoste S; Erickson N
    Can Vet J; 2018 Dec; 59(12):1311-1319. PubMed ID: 30532289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunity.
    Blodörn K; Hägglund S; Gavier-Widen D; Eléouët JF; Riffault S; Pringle J; Taylor G; Valarcher JF
    BMC Vet Res; 2015 Mar; 11():76. PubMed ID: 25890239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of bovine respiratory syncytial virus infection of cattle.
    Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2012 May; 35(3):253-7. PubMed ID: 22410266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination against respiratory syncytial virus in young calves.
    Taylor G; Bruce C; Barbet AF; Wyld SG; Thomas LH
    Vaccine; 2005 Jan; 23(10):1242-50. PubMed ID: 15652666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
    Riffault S; Meyer G; Deplanche M; Dubuquoy C; Durand G; Soulestin M; Castagné N; Bernard J; Bernardet P; Dubosclard V; Bernex F; Petit-Camurdan A; Deville S; Schwartz-Cornil I; Eléouët JF
    Vaccine; 2010 May; 28(21):3722-34. PubMed ID: 20307593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.